Recombinant Human INSL4 (C-6His)

Description

EnkiLife provides the Recombinant Human INSL4 (C-6His) protein,aslo know as Early Placenta Insulin-Like Peptide,EPIL,Insulin-Like Peptide 4,Placentin,INSL4, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Early Placenta Insulin-Like Peptide is produced by our Mammalian expression system and the target gene encoding Ala26-Thr139 is expressed with a 6His tag at the C-terminus.Accession:Q14641. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:13.6 KDa. Background:Early Placenta Insulin-Like Peptide (INSL4) belongs to the insulin family. INSL4 is expressed in the early placental cytotrophoblast and syncytiotrophoblast INSL4 is a secreted protein and a precursor that undergoes post-translational cleavage to produce 3 polypeptide chains, A-C, that form tertiary structures composed of either all three chains, or just the A and B chains. INSL4 plays an important role in the development of trophoblast and in the regulation of bone formation.